Fufeng Group (546)
Fufeng Group Ltd. engages in the manufacture and sale of fermentation based food additive biochemical and starch based products. It operates through the Monosodium Glutamate (MSG) and Xanthan gum segments. The Monosodium Glutamate segment involves in the production of monosodium glutamate, corn refined products, fertilizers, starch sweeteners, threonine, lysine, and high-end amino acid products. The Xantham Gum segment engages in the manufacture and sale of xanthan gum used for food, industrial, and pharmaceutical purposes. The company was founded in 1942 and is headquartered in Linyi, China.
|Market Price at 20-11-2017
|Price to Earnings Ratio
|Return on Equity (ROE)
Blog posts that reference Fufeng Group:
Monday, May 01, 2017
European equities rally following Macron’s entry in the second round of France’s presidential election
• US equity markets climb higher on account of upbeat corporate earnings.
• European equities rally following Macron’s entry in the second round of France’s presidential election.
• Largely positive global cues directs most Asian indices upwards.
Strong earnings and stable global cues power US equities higher
Wall Street finished the week in the green, as gains in the Technology, Industrials sectors and Consumer Services stocks pushed indices higher. The Dow Jones rose by 1.9%, the S&P 500 by 1.5%, and the NASDAQ added 2.3% to its value during the week. The week started on a positive note following the first round of France’s presidential elections, as Emmanuel Macron, a pro-EU candidate, won the most number of votes in Sunday’s election. Stocks continued to climb higher for most part of the week on the back of encouraging first quarter results, as McDonald’s Caterpillar, Amazon and DuPont all reported higher than expected earnings. During the week, Trump administration unveiled its tax reform plan that proposes to reduce the US tax rate on corporate pass-through business profits to 15% from 35%. Administration also proposed significant changes to personal taxes. The stock market took its time to digest the tax reform plan as Wall Street retreated briefly subsequent to the announcement. Moreover, US indices also suffered following the release of first quarter GDP data; US GDP grew at 0.7% in the first quarter of 2017, below the 1.2% rise estimated by economists. However, rally in the first part of the week more than made up for the second-half decline, as most indices finished the week higher.
Monday, February 23, 2015
Why does Roger still like Infomedia even though it’s expensive? Should investors hold cash? Why doesn’t Roger invest in resource companies? Is it wise to accept stock tips from your neighbour? Watch this video to hear Roger’s opinions.
Tuesday, January 21, 2014
Buying top-notch stocks at below their true value is the hallmark of successful value investors.
For the past two years Money magazine has asked Skaffold.com to name the Top 50 undervalued stocks, including five standouts.
Skaffold’s 2013 top stocks produced exceptional results and outperformed the All Ords Accumulation Index, as our 2012 portfolio had done the previous year. Assuming you invested $50,000 equally across the 2012 Top 5 stocks on 10 January 2012, sold on 11 January 2013, then purchased the 2013 Top 5 stocks, and sold on 10 January 2014, your 2 year return, including capital gains and income, would be 21.3% p.a.. Over the same period the All Ords Accumulation Index returned 17.5% p.a.. Skaffold’s Top Stocks outperformed the Index by 3.8% p.a.. That equates to $4,560 more profit in your pocket.
On 6 February 2014 Money magazine will hit the newsstands, unveiling Skaffold’s top stocks for 2014, which for the first time includes global shares.
Until then, here is a rundown on Skaffold’s 2012 and 2013 Money portfolios, and how the stocks stack up in Skaffold today.
Wednesday, May 15, 2013
Whilst there will always be opportunities in Australia, it is now easier than ever to diversify your portfolio and access a broader range of opportunities that are only available through overseas exchanges.
Recent research found that almost 50% of Skaffold members believe global markets will offer the best growth over the next 12 months, compared to just 9% who thought the ASX would offer the highest returns.
For investors seeking value stocks right now US stocks that make the grade include Oracle Corporation (ORCL), Ben Bath & Beyond (BBBY), Amgen Inc (AMGN), Fossil Inc (FOSL) and Global Payments Inc (GPN). Read on to discover the other opportunities we found in Skaffold Global the recently.